Phosphodiesterase 4 and compartmentalization of cyclic AMP signaling

Chinese Science Bulletin

Volumn 52, Issue 1, 2007, Pages 34-46

  Wang, ZhengChao ^a   Shi, FangXiong ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

cAMP signaling; Granulosa cell; PDE4; Phosphodiesterase; Signal compartmentalization

Indexed keywords

RATTUS;

EID: 33846408365     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-007-0025-3     Document Type: Review

References (54)

1. Houslay M D, Schafer P, Zhang K Y. Keynote review: Phosphodi-esterase-4 as a therapeutic target. Drug Discov Today, 2005, 10(22): 1503-1519
2. Conti M, Richter W, Mehats C, et al. Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem, 2003, 278(8): 5493-5496
3. Houslay M D, Milligan G. Tailoring cAMP signalling responses through isoform multiplicity. Trends Biochem Sci, 1997, 22: 217-224
4. Beavo J A, Brunton L L. Cyclic nucleotide research-still expanding after half a century. Nat Rev Mol Cell Biol, 2002, 3: 710-718
5. Evellin S, Mongillo M, Terrin A, et al. Measuring dynamic changes in cAMP using fluorescence resonance energy transfer. Methods Mol Biol, 2004, 284: 259-270
6. Houslay M D, Adams D R. PDE4 cAMP phosphodiesterases: Modu-lar enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem J, 2003, 370(Pt 1): 1-18
7. Henn V, Stefan E, Baillie G S, et al. Compartmentalized cAMP signal-ling regulates vasopressin-mediated water reabsorption by controlling aquaporin-2. Biochem Soc Trans, 2005, 33(Pt 6): 1316-1318
8. Huang T, McDonough C B, Abel T. Compartmentalized PKA sig-naling events are required for synaptic tagging and capture during hippocampal late-phase long-term potentiation. Eur J Cell Biol, 2006, 85: 635-642
9. Alto N M, Scott J D. The role of A-kinase anchoring proteins in camp-mediated signal transduction pathways. Cell Biochem Biophys, 2004, 40(3 Suppl): 201-208
10. Levine C G, Mitra D, Sharma A, et al. The efficiency of protein compartmentalization into the secretory pathway. Mol Biol Cell, 2005, 16(1): 279-291
11. Wang Z, Huang R, Pan L, et al. Molecular structures, physiological roles and regulatory mechanisms of cyclic nucleotide-gated ion channels. Chin J Biochem Mol Biol (in Chinese), 2006, 22(4): 282-288
12. Dousa T P. Cyclic-3′,5′-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney. Kidney Int, 1999, 55(1): 29-62
13. Matsumoto T, Kobayashi T, Kamata K. Phosphodiesterases in the vascular system. J Smooth Muscle Res, 2003, 39(4): 67-86
14. Beard M B, Olsen A E, Jones R E, et al. UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions. J Biol Chem, 2000, 275: 10349-10358
15. Lugnier C. Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents. Pharmacol Therapeut, 2006, 109: 366-398
16. Torphy T J. Phosphodiesterase isozymes: Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med, 1998, 157(2): 351-370
17. Conti M, Jin S L. The molecular biology of cyclic nucleotide phos-phodiesterases. Prog Nucleic Acid Res Mol Biol, 1999, 63: 1-38
18. Conti M. Phosphodiesterases and cyclic nucleotide signaling in en-docrine cells. Mol Endocrinol, 2000, 14(9): 1317-1327
19. Mehats C, Andersen C B, Filopanti M, et al. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol Metab, 2002, 13(1): 29-35
20. Huston E, Houslay T M, Baillie G S, et al. cAMP phosphodi-esterase-4A1 (PDE4A1) has provided the paradigm for the intracel-lular targeting of phosphodiesterases, a process that underpins com-partmentalized cAMP signalling. Biochem Soc Trans, 2006, 34(Pt 4): 504-509
21. Jin S L, Bushnik T, Lan L, et al. Subcellular localization of rolip-ram-sensitive, cAMP-specific phosphodiesterases. Differential tar-geting and activation of the splicing variants derived from the PDE4D gene. J Biol Chem, 1998, 273(31): 19672-19678
22. Perry S J, Baillie G, Kohout T A, et al. Targeting of cyclic AMP deg-radation to beta 2-adrenergic receptors by beta-arrestins. Science, 2002, 298: 834-836
23. Baillie G S, Houslay M D. Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin Cell Biol, 2005, 17(2): 129-134
24. Wong W, Scott J D. AKAP signalling complexes: Focal points in space and time. Nat Rev Mol Cell Biol, 2004, 5(12): 959-970
25. Bolger G B, Baillie G S, Li X, et al. Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5. Biochem J. 2006, 398(1): 23-36
26. Tasken K, Stokka A J. The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem Soc Trans. 2006, 34(Pt 4): 476-479
27. Tasken K, Aandahl E M. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev, 2004, 84: 137-167
28. Cooper D M. Compartmentalization of adenylate cyclase and cAMP signalling. Biochem Soc Trans, 2005, 33(Pt 6): 1319-1322
29. Houslay M D, Baillie G S. Phosphodiesterase-4 gates the ability of protein kinase A to phosphorylate G-protein receptor kinase-2 and influence its translocation. Biochem Soc Trans, 2006, 34(Pt 4): 474-475
30. Willoughby D, Wong W, Schaack J, et al. An anchored PKA and PDE4 complex regulates subplasmalemmal cAMP dynamics. EMBO J, 2006, 25(10): 2051-2061
31. Ji J, Zhang X, Li B. β-adrenergic modulation of in vivo long-term potentiation in area CA1 and its role in spatial learning in rats. Sci China Ser C-Life Sci, 2003, 46(6): 605-614
32. McConnachie G, Langeberg L K, Scott J D. AKAP singaling com-plexs: Getting to the heart of the matter. Trends in Mol Med, 2006, 12(7): 317-323
33. Lim J, Pahlke G., Conti M. Activation of the cAMP-specific phos-phodiesterase PDE4D3 by phosphorylation. Identification and function of an inhibitory domain. J Biol Chem, 1999, 274: 19677-19685
34. Hoffmann R, Wilkinson IR, McCallum JF, et al. cAMP-specifc phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phos-phorylation of Ser-54: Generation of a molecular model. Biochem J, 1998, 333: 139-149
35. Busch C J, et al. Nitric oxide induces phosphodiesterasse 4B expres-sion in rat pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2006, 290(4): L747-L753
36. Tian Z X, Mao X J, Su W. Exogenous cAMP upregulates the expres-sion of glnII and glnK-amtB genes in Sinorhizobium meliloti 1021. Chin Sci Bull, 2006, 51(16): 1982-1985
37. Li P, Wang Z W, Yan J. Neuro-protective effects of CNTF on hippocampal neurons via an unknown signal transduction pathway. Chin Sci Bull, 2006, 51(1): 48-53
38. Li Z, Sun Y, Mao X. cAMP receptor protein (CRP) downregulates Klebsiella pneumoniae nif promoters in Escherichia coli. Chin Sci Bull, 2002, 47(19): 1622-1628
39. Oki N, Takahashi S I, Hidaka H, et al. Short term feedback regulation of cAMP in FRTL-5 thyroid cells. Role of PDE4D3 phosphodi-esterase activation. J Biol Chem, 2000, 275: 10831-10837
40. Jin S-L C, Richard F, Kuo W P, et al. Impaired growth and fertility of cAMP-specific phosphodiesterase PDE4D-deficient mice. Proc Natl Acad Sci USA, 1999, 96: 11998-12003
41. Hansen G, Jin S-L C, Umetsu D, et al. Absence of muscarinic cho-linergic airway responses in mice deficient in the cyclic nucleotide phosphodiesterase PDE4D. Proc Natl Acad Sci USA, 2000, 97: 6751-3756
42. Hoffmann R., Baillie G S, MacKenzie S J, et al. The MAP kinase ERK2 inhibits the cAMP-specifc phosphodiesterase, HSPDE4D3 by phosphorylating it at Ser579. EMBO J, 1999, 18: 893-903
43. Houslay M D, Kolch W. Cell-type specifc integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol Pharmacol, 2000, 58: 659-668
44. Dodge-Kafka K L, Soughayer J, Pare G C, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature, 2005, 437: 574-578
45. Park J Y, Richard F, Chun S Y, et al. Phosphodiesterase regulation is critical for the differentiation and pattern of gene expression in granulosa cells of the ovarian follicle. Mol Endocrinol, 2003, 17(6): 1117-1130
46. Shi F, Perez E, Wang T, et al. Stage and cell-specific expression of soluble guanylyl cyclase alpha and beta subunits, cGMP-Dependent protein kinase I-alpha and I-beta, cyclic nucleotide-gated channel subunit-1 in the rat testis. J Androl, 2005, 26(2): 258-263
47. Shi F, Stewart R L, Pere E, et al. Cell-specific expression and regulation of soluble guanylyl cyclase alpha and beta subunit in the rat ovary. Bio Reprod, 2004, 70: 1552-1561
48. Shi F, LaPolt P S. Relationship between FoxO1 protein levels and follicular development, atresa, and luteinization. J Endocr. 2003, 179: 195-203
49. Li X, Jiang Y, Wang Z, et al. Regulation of FoxO1 transcription factor by nitric oxide and cyclic GMP in cultured rat granulosa cells. Zoolog Sci, 2005, 22: 1339-1346
50. Li X, Xie Z, Shi F. Involvement of forkhead box proteins in apoptosis and oncogenesis. Prog Biochem Biophys (in Chinese), 2005, 32(7): 600-606
51. Shen Z, Zhao X, Cao Y. Regulation of mouse blastocyst adhesion, outgrowth and secretion of matrix metalloproteinase-2 by cGMP and nitric oxide in vitro. Chin Sci Bull, 2004, 49(11): 1142-1145
52. Conti M, Andersen C B, Richard F, et al. Role of cyclic nucleotide signaling in oocyte maturation. Mol Cell Endocrinol, 2002, 187(1-2): 153-159
53. Paruthiyil S, Majdoubi M E, Conti M, et al. Phosphodiesterase ex-pression targeted to gonadotropin-releasing hormone neurons inhibits luteinizing hormone pulses in transgenic rats. Proc Natl Acad Sci USA, 2002, 99(26): 17191-17196
54. Sadler SE. Type III phosphodiesterase plays a necessary role in the growth-promoting actions of insulin, insulin-like growth factor-I, and Ha p21ras in Xenopus laevis oocytes. Mol Endocrinol, 1991, 5: 1939-1946